A Highly Selective and Versatile Probe Platform for Visualization of Monoacylglycerol Lipase
Angewandte Chemie International Edition, vol. 64, pp. e202413405
Abstract
Monoacylglycerol lipase (MAGL) is a key enzyme for signal termination in the endocannabinoid system (ECS). MAGL inhibition results in indirect activation of the cannabinoid receptors, which offers unique advantages for the treatment of, e.g., multiple sclerosis, epilepsy, and other neurological disorders. Molecular imaging techniques are valuable tools to overcome the current poor understanding of MAGL's distribution and role in patho- and physiological processes within ECS signaling. Herein, we report the design, synthesis, and validation of highly selective versatile fluorescent and click-chemistry probes for MAGL. Structure-based design combined with a reverse-design approach allowed the development of a structural unit that selectively and effectively recognizes MAGL while offering a versatile platform to attach different fluorophores and further reporter units. In this way, labeled probes with sub-nanomolar potency carrying diverse fluorescent dyes were obtained. Probe affinity and selectivity remained invariant to changes in the fluorophore subunit, showing the remarkable robustness of this platform in delivering tailor-made probes. Highly consistent inhibition across species supports pharmacological model translatability. Extensive profiling and validation in various cellular systems shows the ability of these highly potent and selective probes to elucidate the complex role of MAGL in ECS cellular signaling, inflammatory processes, and disease progression.
Authors 19
-
Leibniz-Forschungsinstitut für Molekulare Pharmakologie
Affiliation as printed
Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) Robert-Roessle-Strasse 10 13125 Berlin GER
These authors contributed equally to this work
-
Leibniz-Forschungsinstitut für Molekulare Pharmakologie
Affiliation as printed
Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) Robert-Roessle-Strasse 10 13125 Berlin GER
These authors contributed equally to this work
-
Leibniz-Forschungsinstitut für Molekulare Pharmakologie
Affiliation as printed
Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) Robert-Roessle-Strasse 10 13125 Berlin GER
-
Affiliation as printed
Leiden Institute of Chemistry (LIC) Universiteit Leiden Einsteinweg 55 2333 CC Leiden NL
Leiden Institute of Chemistry (LIC), Universiteit Leiden, Einsteinweg 55, 2333 CC Leiden, NL
-
Leibniz-Forschungsinstitut für Molekulare Pharmakologie
Affiliation as printed
Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) Robert-Roessle-Strasse 10 13125 Berlin GER
-
Affiliation as printed
Pharma Research & Early Development (pRED) F. Hoffmann-La Roche Ltd Grenzacherstrasse 124 CH-4070 Basel CH
Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070 Basel, CH
-
Affiliation as printed
Pharma Research & Early Development (pRED) F. Hoffmann-La Roche Ltd Grenzacherstrasse 124 CH-4070 Basel CH
Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070 Basel, CH
-
Affiliation as printed
Pharma Research & Early Development (pRED) F. Hoffmann-La Roche Ltd Grenzacherstrasse 124 CH-4070 Basel CH
Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070 Basel, CH
-
Affiliation as printed
Pharma Research & Early Development (pRED) F. Hoffmann-La Roche Ltd Grenzacherstrasse 124 CH-4070 Basel CH
Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070 Basel, CH
-
Affiliation as printed
Pharma Research & Early Development (pRED) F. Hoffmann-La Roche Ltd Grenzacherstrasse 124 CH-4070 Basel CH
Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070 Basel, CH
-
Affiliation as printed
Pharma Research & Early Development (pRED) F. Hoffmann-La Roche Ltd Grenzacherstrasse 124 CH-4070 Basel CH
Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070 Basel, CH
-
Affiliation as printed
Pharma Research & Early Development (pRED) F. Hoffmann-La Roche Ltd Grenzacherstrasse 124 CH-4070 Basel CH
Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070 Basel, CH
-
Leibniz-Forschungsinstitut für Molekulare Pharmakologie
Affiliation as printed
Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) Robert-Roessle-Strasse 10 13125 Berlin GER
-
Affiliation as printed
Pharma Research & Early Development (pRED) F. Hoffmann-La Roche Ltd Grenzacherstrasse 124 CH-4070 Basel CH
Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070 Basel, CH
-
Affiliation as printed
Pharma Research & Early Development (pRED) F. Hoffmann-La Roche Ltd Grenzacherstrasse 124 CH-4070 Basel CH
Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070 Basel, CH
-
Affiliation as printed
Leiden Institute of Chemistry (LIC) Universiteit Leiden Einsteinweg 55 2333 CC Leiden NL
Leiden Institute of Chemistry (LIC), Universiteit Leiden, Einsteinweg 55, 2333 CC Leiden, NL
-
Leibniz-Forschungsinstitut für Molekulare Pharmakologie
Affiliation as printed
Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) Robert-Roessle-Strasse 10 13125 Berlin GER
-
Uwe Grether corresponding
Affiliation as printed
Pharma Research & Early Development (pRED) F. Hoffmann-La Roche Ltd Grenzacherstrasse 124 CH-4070 Basel CH
Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070 Basel, CH
-
Marc Nazaré corresponding
Leibniz-Forschungsinstitut für Molekulare Pharmakologie
Affiliation as printed
Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) Robert-Roessle-Strasse 10 13125 Berlin GER
Cited by 11 stored of 10
11 results
No patents citing this paper on Lens.org (checked 2026-10-11).